Cargando…

Update on diagnosis and treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis is a type of chronic fibrosing interstitial pneumonia, of unknown etiology, which is associated with a progressive decrease in pulmonary function and with high mortality rates. Interest in and knowledge of this disorder have grown substantially in recent years. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baddini-Martinez, José, Baldi, Bruno Guedes, da Costa, Cláudia Henrique, Jezler, Sérgio, Lima, Mariana Silva, Rufino, Rogério
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635093/ https://www.ncbi.nlm.nih.gov/pubmed/26578138 http://dx.doi.org/10.1590/S1806-37132015000000152

Ejemplares similares

Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2019)

Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology
por: Baddini-Martinez, José, et al.
Publicado: (2020)

Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics
por: Hochhegger, Bruno, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

How many patients with idiopathic pulmonary fibrosis are there in Brazil?
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis can be a transient diagnosis
por: de Oliveira, Martina Rodrigues, et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Update on therapeutic management of idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2015)

Combined pulmonary fibrosis and emphysema: an increasingly recognized condition
por: Dias, Olívia Meira, et al.
Publicado: (2014)

Familial pulmonary fibrosis: a heterogeneous spectrum of presentations
por: Hortense, Ana Beatriz, et al.
Publicado: (2019)

Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis
por: Aburto, Myriam, et al.
Publicado: (2018)

Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification
por: Baldi, Bruno Guedes, et al.
Publicado: (2021)

Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
por: Thong, Lorraine, et al.
Publicado: (2023)

Pleural Cholesterol to the Diagnosis of Exudative Effusion
por: Rufino, Rogério, et al.
Publicado: (2014)

Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?
por: Bridi, Guilherme das Posses, et al.
Publicado: (2023)

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
por: Cottin, Vincent, et al.
Publicado: (2014)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics
por: Costabel, U, et al.
Publicado: (2013)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: the need for early diagnosis
por: Cicchitto, Gaetano, et al.
Publicado: (2013)

Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
por: Nakamura, Yutaro, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
por: Amaral, Alexandre Franco, et al.
Publicado: (2023)

Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function
por: Mafort, Thiago Thomaz, et al.
Publicado: (2016)

Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up
por: Vilela, Verônica Silva, et al.
Publicado: (2021)

Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Moran-Mendoza, Onofre
Publicado: (2022)

Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis
por: Cordeiro, Carlos Robalo, et al.
Publicado: (2013)

Idiopathic pulmonary fibrosis: the radiologist’s role in making the diagnosis
por: Mohning, Michael P., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Sleep Apnea Clinical Score, Berlin Questionnaire, or Epworth Sleepiness Scale: which is the best obstructive sleep apnea predictor in patients with COPD?
por: Faria, Anamelia Costa, et al.
Publicado: (2015)

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
por: Raghu, Ganesh, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
por: van Cleemput, Johan, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis: pathogenesis and management
por: Sgalla, Giacomo, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Physiology of the lung in idiopathic pulmonary fibrosis
por: Plantier, Laurent, et al.
Publicado: (2018)

Evaluation of von Willebrand factor in COPD patients
por: Bártholo, Thiago Prudente, et al.
Publicado: (2014)

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics Concluding remarks
por: Costabel, Ulrich
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8grsf80hl2dq762ggijb6r2vib